As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: October 7, 2017
by Alzheimer’s Society:
Women who develop high blood pressure in their 40s may be more likely to develop dementia later in life, according to a study published today, 4 October 2017, in the medical journal Neurology.
7,238 people within the Kaiser Permanente Northern California health care system participated in the study. The researchers found that women who developed high blood pressure in their thirties and fourties were 73% more likely to develop dementia than women who had stable, normal blood pressure throughout these years.
Dr Doug Brown, Director of Research at Alzheimer’s Society, said:
“It is a well-established fact that high blood pressure in mid-life can increase our chances of developing dementia in later life. Previous research has shown links between hypertension and dementia among both sexes so this work suggesting a link in women but not men is surprising.
The younger age of people involved in this study compared to previous ones may partly explain the difference, but as this new research goes against the grain we need to see more studies to fully understand possible sex differences in blood pressure and dementia risk.
We should be mindful that this study tested the blood pressure of people in a particular health-scheme in Northern California in the 1960s and 70s. Since then there have been advances in how blood pressure is treated – so it’s not clear how relevant the findings of this study are to the present UK population.
The Lancet Commission on dementia suggested there is good evidence that treatment of hypertension reduces the chances of developing the condition. We also know that keeping in good health may help reduce your risk of dementia and the NHS recommends that people over 40 should have blood pressure tested every five years with their GP or pharmacy.”
Thirty-six million people worldwide suffer from Alzheimer’s disease and dementia. In Canada, 25,000 new cases are diagnosed each year. Those sobering numbers have researchers around the globe racing to come up with new ways to...
he Food and Drug Administration issued new guides on drug development for neurological disorders. This sets the stage for possible treatments for Alzheimer’s. The disease-oriented development guide documents will provide details on how researchers...
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology. Yakeel T. Quiroz, Ph.D., from Massachusetts...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.